Cognitive Function and Fatigue in Stable Multiple Sclerosis: EDSS and MRI Assessments Surpass Serum Biomarkers - Quiz - MDSpire

Cognitive Function and Fatigue in Stable Multiple Sclerosis: EDSS and MRI Assessments Surpass Serum Biomarkers

  • By

  • Deborah K. Erhart

  • Luisa T. Balz

  • Roland Opfer

  • Lothar Spies

  • Franziska Bachhuber

  • Ioannis Vardakas

  • Daniela Taranu

  • Stefanie Jung

  • Tanja Fangerau

  • Makbule Senel

  • Kornelia Kreiser

  • Ingo Uttner

  • Dorothée Lulé

  • Hayrettin Tumani

  • April 17, 2026

  • 0 min

Share

Original Source(s)

Cognitive Function and Fatigue in Stable Multiple Sclerosis: EDSS and MRI Assessments Surpass Serum Biomarkers

  • by Deborah K. Erhart, Luisa T. Balz, Roland Opfer, Lothar Spies, Franziska Bachhuber, Ioannis Vardakas, Daniela Taranu, Stefanie Jung, Tanja Fangerau, Makbule Senel, Kornelia Kreiser, Ingo Uttner, Dorothée Lulé, Hayrettin Tumani

  • April 17, 2026

Related Content

Partial sensory rhizotomy in therapy-refractory and recurrent trigeminal neuralgia – a single center experience

Now Enrolling: Real-World Registry Study of BRUMVI (Ublituximab-xiiy) in Relapsing Multiple Sclerosis

Baptist Health Brain & Spine Care is enrolling patients with confirmed multiple sclerosis who are starting BRUMVI to track outcomes, safety, and patient experience over time in a real-world setting.

  • by

  • March 4, 2026

  • 2 min
Long-Term Outcomes of Ublituximab Treatment in Multiple Sclerosis: Findings from the ULTIMATE I and II Open-Label Extension Trials